Hypotension duration and vasopressor requirements following intrathecal oxytocin for Total hip arthroplasty: Secondary analysis of a randomized controlled trial.

Henshaw DS, Khanna AK, Edwards CJ, Eisenach JC. J Clin Anesth. 2023 Jun; 89:111189.

Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: a prospective observational trial.

Henshaw DS, Edwards CJ, Dobson SW, Jaffe D, Turner JD, Reynolds JW, Thompson GR, Russell G, Weller R. Reg Anesth Pain Med. 2023 Jun;

Comparison of Femoral Nerve Catheter, Adductor Canal Catheter, and Periarticular Liposomal Bupivacaine Infiltration for Postoperative Analgesia After Primary Total Knee Arthroplasty.

Dobson SW, Stouffer ND, Weller RS, Shields JS, Edwards CJ, Henshaw DS. J Arthroplasty. 2022 Dec;

Angiotensin II treatment of hypotension in noncardiac surgery: an initial dose-finding study.

Fernando RJ, Royster RL, Ferrario CM, Saha AK, Ahmad S, Henshaw DS, Kittner SL, Talbott AL, Khanna AK, Morris BN, Groban L, Templeton TW. Br J Anaesth. 2024 Jun;

Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: an infographic.

Henshaw DS, Schwenk ES, Gupta RK. Reg Anesth Pain Med. 2023 Aug;

Surface Landmarks in the Lateral Decubitus Position Are Unreliable for Thoracic Epidural Catheter Placement: A Case Series.

Dobson SW, Weller RS, Turner JD, Lack CM, Henshaw DS. A A Pract. 2022 Dec; 16(12):e01649.